CryoCor, Inc. Says FDA Requests More Data On Heart Device

November 3, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK, Nov 3 (Reuters) - CryoCor Inc. (CRYO.OQ: Quote, Profile, Research) on Thursday said it has provided more data to U.S. regulators to support its premarket approval application for its heart system to treat atrial flutter.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)